2 results match your criteria: "East Tennessee Pulmonary Hypertension Center[Affiliation]"
The Evolving Management and Treatment Options for Patients with Pulmonary Hypertension: Current Evidence and Challenges.
Vasc Health Risk Manag
March 2023
East Tennessee Pulmonary Hypertension Center, StatCare Pulmonary Consultants, Knoxville, TN, USA.
Pulmonary hypertension may develop as a disease process specific to pulmonary arteries with no identifiable cause or may occur in relation to other cardiopulmonary and systemic illnesses. The World Health Organization (WHO) classifies pulmonary hypertensive diseases on the basis of primary mechanisms causing increased pulmonary vascular resistance. Effective management of pulmonary hypertension begins with accurately diagnosing and classifying the disease in order to determine appropriate treatment.
View Article and Find Full Text PDFAge-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry.
J Heart Lung Transplant
September 2020
Department of Medicine, University of California, San Francisco, San Francisco, California.
Background: The age of patients with pulmonary arterial hypertension (PAH) has increased, with registries now reporting mean ages of 50 to 65 years old. Limited data exist on age-related differences in hemodynamic and functional assessments in PAH.
Methods: Adults with PAH in the Pulmonary Hypertension Association Registry were divided into 3 groups (18-50, 51-65, and >65 years old).